ClinicalTrials.gg
RecruitingNCT06189352PoPUpdated Aug 11, 2025

Positive Feeding of the Preterm Infant

An interventional study of Positive feeding of the preterm infant in Preterm Infant, Breast Feeding and Bottle Feeding, sponsored by Oslo Metropolitan University. Recruiting at 1 site in Norway. Per ClinicalTrials.gov, last updated 2025-08-11.

Sponsored by Oslo Metropolitan University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 2 months ago, but the record still lists the study as recruiting.
  • Started Oct 2024; still recruiting 2 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Sex
All
01

Study summary

The goal of this feasibility study is to assess the feasibility to implement a feeding strategy for preterm infants.

The main questions it aims to answer are:

  • Is it feasible to implement the PoP-intervention in a level 3a category Neonatal intensive care unit?
  • Is the PoP-intervention acceptable for parents of preterm infants and health care personnel working in Neonatal intensive care unit?

Parents of preterm infants and health care personnel will be asked to follow a protocol of a feeding strategy based on the preterm infants development and cues throughout the NICU-stay.

Read the detailed description

The parents will be recruited before or as soon as possible after birth. The intervention will start as soon as the parents have given written consent for themselves and behalf of their infant.

The intervention is developed in line with the MRC framework of developing and evaluating complex interventions in an iterative and dynamic way. The intervention will be based on parents counseling and an infant feeding protocol.

02

Conditions studied

  • Preterm Infant
  • Breast Feeding
  • Bottle Feeding
  • Enteral Feeding
  • Cue Based Feeding
  • Develomentally Supportive Care
03

In context

Premature Birth

2,550 studies on the registry are indexed under Premature Birth; 500 are open to participants now.

This study's planned enrollment of 15 is below the median of 84 across 1,666 interventional studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

Oslo Metropolitan University is the lead sponsor of 64 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • gestational age of 28 weeks
  • post menstrual age of 28 weeks after transition from regional hospital

Exclusion criteria

Exclusion Criteria:

  • diagnoses or malformations that makes eating difficult
  • triplets or more
  • parents not speaking/understanding Norwegian or English
  • parents with challenges or special needs for follow up
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Intervention group

    The infants will follow a feeding protocol with detailed nutritional needs, and individual supportive care interventions for enhancing oral feeding development. Parents will get counseling sessions for supporting this strategy. The protocol will follow the infant until discharge.

    Other: Positive feeding of the preterm infant

Interventions

  • OtherPositive feeding of the preterm infant

    Feeding strategy for the preterm infant with description of nutritional needs and based on the infants development and cues.

06

What researchers measure

Primary outcomes

  1. Recruitment rates and sample criteria

    Variables to evaluate if we can recruit appropriate participants, the time frame it takes, the eligibility criterias, the recruitment routines.

    Time frame: Prospective over a period of 1 year

  2. Data collection and outcome variables

    How appropriate are the data collection procedures, the participants ability to complete the quiestionnaires, appropriatness of the amount of data collection, completion of datasets,

    Time frame: Prospective over a period of 1 year

  3. Acceptability

    Evaluation of acceptability of the intervention for the participants, adherence to the study procedures, the burden for participants and the health care personnell conducting the intervention, safety and adverse events

    Time frame: Prospective over a period of 1 year

  4. Resources and organisation

    Evaluation of the resources needed to conduct the study procedures, resources needed for training health care personnel or other costs related to the study

    Time frame: Prospective over a period of 1 year

Secondary outcomes

  1. Infant outcome variables

    A pilotstudy of the intervention with focus on the infants outcomes, such as weight gain, feeding milestones, nutrition, feeding methods,

    Time frame: Prospective over a period of 1 year

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2024 (actual). Primary completion is estimated for Sep 2025, 11 months after the start.

Of 741 non-industry interventional studies with no phase under Premature Birth, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's planned 11 months is below that.

Counting every sponsor, half of 759 studies reached it within 24 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 28, 2023
First posted
Jan 3, 2024
StartActual
Oct 14, 2024
Primary completionEst.
Sep 2025
CompletionEst.
May 2026
Last update
Aug 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06189352
Lead sponsor
Oslo Metropolitan University
Responsible party
Sponsor
First posted
Jan 3, 2024
Start date
Oct 14, 2024
Primary completion
Sep 2025 (estimated)
Completion
May 2026 (estimated)
Last update
Aug 11, 2025

Study contacts

Nina M Kyno, PhD
Contact
ninam@oslomet.no
+4790561929
Linn J Gustavsen, MSc
Contact
linnjahr@oslomet.no
+4797161225
Nina M Kyno, PhD
principal investigator · Oslo Metropolitan University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion